Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Italy researchers prepare new FXR modulators

Dec. 4, 2014

EMA starts review of MAA of NPS Pharmaceuticals' Natpar

Dec. 3, 2014

Synageva BioPharma provides regulatory update for sebelipase alfa

Dec. 3, 2014

Jiangsu Hengrui Medicine patents URAT1 inhibitors

Dec. 3, 2014

Abeona Therapeutics raises funding to support Sanfilippo syndrome program

Dec. 3, 2014

FDA grants fast track status to palovarotene for fibrodysplasia ossificans progressiva

Dec. 2, 2014

Ixazomib granted FDA breakthrough therapy designation in systemic light-chain amyloidosis

Dec. 2, 2014

Icosabutate shows promise as lipid-lowering agent in animal studies and early clinical trials

Dec. 2, 2014

Rinat Neuroscience discloses new anti-glucagon receptor antibodies

Dec. 1, 2014

Novartis applies for approval of vildagliptin/metformin combination tablets in Japan

Nov. 28, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...